Association Between Immune-Related Adverse Events During Anti–PD-1 Therapy and Tumor Mutational Burden

JAMA Oncology - United States
doi 10.1001/jamaoncol.2019.3221
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)


Related search